Abstract
Introduction:
Abundant studies have associated colorectal cancer (CRC) treatment delay with advanced diagnosis and worse mortality. Delay in seeking specialist is a contributor to CRC treatment delay. The goal of this study is to investigate contributing factors to 14-days delay from diagnosis of CRC on colonoscopy to the first specialist visit in the state of Kentucky.
Methods:
The Kentucky Cancer Registry (KCR) database linked with health administrative claims data was queried to include adult patients diagnosed with stage I-IV CRC from January 2007 to December 2012. The dates of last colonoscopy and first specialist visit were identified through the claims. Bivariate and logistic regression analysis were performed to identify factors associated with delay to CRC specialist visit.
Results:
A total of 3,927 patients, from 100 hospitals in Kentucky were included. Approximately 19% of CRC patients visited a specialist more than 14 days after CRC detection on colonoscopy. Delay to Specialist (DTS) was found more likely in patients with Medicaid insurance (OR 3.1, p<0.0001), low and moderate education level (OR 1.4 and 1.3, respectively, p=0.0127), and stage I CRC (OR 1.5, p<0.0001). There was a higher percentage of DTS among Medicaid patients (44.0%) compared to Medicare (18.0%) and privately insured patients (18.8%).
Conclusion:
We identified Medicaid insurance, low education attainment and early stage CRC diagnosis as independent risk factors associated with 14-days delay in seeking specialist care after CRC detection on colonoscopy.
Keywords: Colorectal Cancer, Delays, Eastern Kentucky Appalachia
INTRODUCTION
Colorectal cancer (CRC) is the third leading cause of cancer related mortality in the United States (1). The incidence of CRC in the United States is 145,600 patients with a mortality rate of 51,020 in 2018 (1). According to the American Cancer Society, the state of Kentucky ranked the first in CRC incidence and fifth in mortality in the United States from year 2017 to 2019 (2). Nearly half (54) of 120 counties in eastern Kentucky belongs to the central Appalachia region, which historically carries a worse mortality rate (21.6 per 100,000) compared to its urban non-Appalachian counterpart (20.4 per 100,000)(3). In the past two decades, Kentucky implemented several programs to successfully increase CRC screening, such as clinical module intervention to increase screening in rural Kentucky and the Affordable Care Act Medicaid expansion in 2016 to increase insurance coverage (4–9). These interventions helped to increase the CRC screening rate in Kentucky from 34.7% in 1999 to 70.1% in 2016 (4, 6). Despite these efforts in increasing CRC screening, mortality remains high in Kentucky. This suggests further investigation in other barriers to care for CRC patients, such as prompt treatment delivery.
Delays in diagnosis and treatment initiation were found to be associated with more advanced stage and worse patient survival (10, 11). Several European national healthcare services implemented fast track referral protocols for CRC patients (12–18). One recommendation established by the United Kingdom’s National Health Service was the 14-days referral rule, which recommended patients with symptoms detected by general practitioners to visit a specialist within 14 calendar days (19). Other institutions also utilized similar referral courtesy to have patients seen by a specialist and to initiate treatment within 14 days after CRC diagnosis (14, 16). There is not a common consensus of standard referral waiting times in the United States currently; however, there is a general agreement that minimizing waiting time can reduce anxiety experienced by patients (20–22). At the University of Kentucky Markey Cancer Center, we utilize an expedited referral policy for newly diagnosed CRC patients to establish specialist care within 14 days (23). We define delay to specialist (DTS) care as more than 14 days after CRC detection on colonoscopy.
It is particularly challenging to deliver healthcare to residents of eastern Kentucky Appalachia due to lack of access, resources and low health literacy(24–26). Prior studies reported that determinants such as, lack of presenting symptoms, refusal of care, and false-negative results accounted for DTS and initiation of treatment (27, 28). However, we do not know the contributory factors to DTS. The purpose of this study is to identify factors associated with DTS, which will allow us to implement interventions to deliver prompt CRC care in Kentucky.
PATIENTS AND METHODS:
Patient selection and database
De-identified health claims linked Kentucky Cancer Registry (KCR) dataset was extracted for CRC patients diagnosed with stage I – IV between January 2007, to December 2012. Institutional Review Board approval with waiver for informed consent was obtained from the University of Kentucky’s Office of Research prior to data analysis. To ensure the data accuracy, only patients with at least 13 months of health insurance continuous enrollment (excluding the month of diagnosis, 6 months prior to cancer diagnosis to 6 months after) were included in the study. The final study analytical dataset included 3,927 CRC patients who met the following inclusion criteria: (1) adult patients age ≥ 20; (2) current Kentucky residents; (3) first invasive primary CRC diagnosis; (4) stage I – IV CRC diagnosis (4) receiving treatment within 6 months of diagnosis. According to AJCC guideline, stage 0 / in situ CRC patients diagnosed on colonoscopy and underwent endoscopic resection does not warrant an immediate follow up with specialist(29). Therefore, this group of patients was excluded from our study.
The KCR is a population-based registry and has been awarded the highest level of certification by the North American Association of Central Cancer Registries for an objective evaluation of completeness, accuracy and timeliness every year since 1997. The KCR is also part of the Surveillance, Epidemiology, and End Results (SEER) program, whose data have been widely used for cancer outcome research (30). KCR performed a probabilistic data linkage linking KCR cancer cases with health administrative claim data from Medicaid, Kentucky state employee insurance database and private insurance groups, then consolidated the linked data with SEER Medicare data to create a claim-linked KCR dataset.
Definition of Delay to Specialist (DTS)
Delay time interval was calculated based on date of the latest colonoscopy prior to CRC diagnosis and the first specialist visit after colonoscopy. The date of colonoscopy was limited to within 6 months prior to CRC diagnosis and identified based on ICD-9 codes and HCPC codes (Table 1)(31). The first specialist visit was defined as after the latest colonoscopy and prior to CRC treatment. If no specialist visit was obtained after 6 months of cancer diagnosis, the first treatment date was considered as the date of first specialist visit. The specialist was identified based on corresponding variables from the claim sources, including specialties such as medical oncologist, general surgeon, specialty surgeon, and radiation oncologist. Patients who had delay time interval greater than 14 days were considered the delay group, while within 14 days were considered the early group.
Table 1 –
CPT/HCPCS and ICD-9-CM codes
| CPT/HCPCS and ICD-9 codes used to identify colonoscopy | |
| CPT/HCPCS codesa | |
| 44388–44394 | Under endoscopy, stomal |
| 45378–45386, 45391,45392 | Under endoscopy procedures on the rectum |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk |
| ICD-9-CMb | |
| 45.21 | Transabdominal endoscopy of large intestine |
| 45.22 | Endoscopy of large intestine through artificial stoma |
| 45.23 | Colonoscopy |
| 45.25 | Closed endoscopic biopsy of large intestine |
| 45.41 | Excision of lesion or tissue or large intestine |
| 45.42 | Endoscopic polypectomy of large intestine |
| 45.43 | Endoscopic destruction of other lesion or tissue or large intestine |
| 48.36 | Endoscopic polypectomy of rectum |
CPT/HCPCS – Current Procedural Terminology/Healthcare Common Procedure Coding System
ICD-9-CM – International Classification of Disease, Ninth Revision, Clinical Modification
Data variables
The following demographic variables were included in our analysis: age at diagnosis, race, gender, education attainment, poverty status, rural status, Appalachian status, disability status, insurance type, hospital type and distance to hospital. Education attainment and poverty status was determined by high school completion rate and percentage of population below poverty income within the 2000 Census tract. Education attainment was categorized into three levels based on the tertiles of corresponding distributions: low education group (high school completion rate less than 67.9%); moderate education group (high school completion rate between 67.9% to 79.2%), and high education group (high school completion rate of 79.2% or higher). High poverty index group reside in area with 18.9% or above population below poverty income, while low poverty index patients live in area with less than 9.7% population below poverty income. Appalachian status was determined by the Appalachia Regional Commission (32). The patient’s disability status was defined using the corresponding variables from claim sources. For Medicaid patients, long term disability coverage was considered as disabled. The type of hospital was categorized as large academic hospital (University of Louisville and University of Kentucky), large non-academic hospital (reporting 100 ≥ cancer cases per year), small non-academic hospital (reporting < 100 cancer cases per year), and out-of-state hospital. Since the institute of the specialist was de-identified, we estimated the distance from the registered residence to the hospital where patients received treatment to calculate the great circle distance, proposed by NAACCR (33). If the hospital where patients received treatment was not available, the hospital where claims were generated was used to calculate great circle distance. Socioeconomic status was categorized based on education, income level, poverty percentage, occupation or social grouping, and other defining matrix (i.e Jarman index, Townsend deprivation score, Elley-Irving Scale, Nam-Powers score) (34–37).
The following clinical variables were also included: stage, tumor grade, and Charlson comorbidity Index (CCI). Stage and tumor grade were defined using American Joint Committee of Cancer (AJCC) staging manual(38). CCI was calculated using the modified version for claim data and categorized into four categories (0, 1, 2 and 3+) (39).
Statistical analysis
A descriptive analysis of the follow-up interval, demographic and clinical factors was performed. We used χ2 tests to examine associations between DTS and variables described above in the bivariate analysis. Logistic regressions were fitted to identify significant factors associated with DTS while controlling for other covariates. A sensitivity analysis was performed with and without missing and unknown variables. Goodness of fit was also tested. All analyses were performed using SAS Statistical software version 9.4 (SAS Institute, Inc., Cary, North Carolina, USA). All statistical tests were two sided with a P-value ≤ 0.05 to identify statistical significance. The EQUATOR/STROBE checklist was used to guide organization of the epidemiologic study(40).
RESULTS
Patient demographics, disease characteristics and functional status: Stage I CRC was independently associated with DTS
A total of 3,927 patients were included from years January 2007 to December 2012. Two (2) large academic hospitals, 38 large non-academic hospitals and 60 small non-academic hospitals were included. Approximately 19.0% of newly diagnosed CRC patients (n=753) experienced DTS. Among patients who experienced DTS, the median was 23 days with an interquartile range of 17 days. The bivariate analyses demonstrated that younger patients, both age group 20–49 year-old and 50–64 year-old (22.8% and 23.8%, respectively) have higher percentage experiencing DTS compared to elderly patients age ≥ 75 years old (15.9%, p<0.0001). There was no statistical difference in terms of gender and racial groups (Caucasians, African-Americans, and others) (Table 2).
Table 2 –
Bivariate analysis of patient demographics, disease burden factors, and socioeconomic status/rurality on 14-days delay in seeking specialist after colorectal cancer diagnosis on colonoscopy.
| Percentage of Patients Experiencing 14-days Delay to Specialist | |||||
|---|---|---|---|---|---|
| Variable (s) | Early (n) | % | Delay (n) | % | p-value |
| Total | 3174 | 80.83 | 753 | 19.17 | |
|
Patient demographics | |||||
| Age (years old) | <0.0001 | ||||
| 20–49 | 169 | 77.17 | 50 | 22.83 | |
| 50–64 | 563 | 76.18 | 176 | 23.82 | |
| 65–74 | 1149 | 80.29 | 282 | 19.71 | |
| 75+ | 1293 | 84.07 | 245 | 15.93 | |
| Race | 0.4407 | ||||
| Caucasian | 2988 | 80.87 | 707 | 19.13 | |
| African-American | 166 | 81.37 | 38 | 18.63 | |
| Other | 20 | 71.43 | 8 | 28.57 | |
| Sex | 0.8865 | ||||
| Male | 1601 | 80.74 | 382 | 19.26 | |
| Female | 1573 | 80.92 | 371 | 19.08 | |
|
Disease characteristics and functional status | |||||
| Stage | <0.0001 | ||||
| Stage I | 930 | 75.98 | 294 | 24.02 | |
| Stage II | 918 | 85.47 | 156 | 14.53 | |
| Stage III | 848 | 83.96 | 162 | 16.04 | |
| Stage IV | 338 | 82.24 | 73 | 17.76 | |
| Stage Unknown | 140 | 67.31 | 68 | 32.69 | |
| Grade | <0.0001 | ||||
| Well differentiated | 136 | 73.51 | 49 | 26.49 | |
| Moderately- differentiated | 2270 | 81.80 | 505 | 18.20 | |
| Poorly differentiated | 339 | 83.09 | 69 | 16.91 | |
| Un-Differentiated | 211 | 86.83 | 32 | 13.17 | |
| Grade Unknown | 218 | 68.99 | 98 | 31.01 | |
| CCIa | 0.3047 | ||||
| 0 | 1690 | 81.64 | 380 | 18.36 | |
| 1 | 811 | 79.98 | 203 | 20.02 | |
| 2 | 354 | 81.57 | 80 | 18.43 | |
| 3+ | 319 | 78.00 | 90 | 22.00 | |
| Disable Status | 0.0022 | ||||
| Not Disabled | 2475 | 81.98 | 544 | 18.02 | |
| Disable | 377 | 78.22 | 105 | 21.78 | |
| Unknown | 322 | 75.59 | 104 | 24.41 | |
|
Socioeconomic status | |||||
| Education Attainmentb | <0.0001 | ||||
| Low | 1024 | 77.63 | 295 | 22.37 | |
| Moderate | 1041 | 79.77 | 264 | 20.23 | |
| High | 1109 | 85.11 | 194 | 14.89 | |
| Poverty levelc | <0.0001 | ||||
| Low | 1108 | 84.77 | 199 | 15.23 | |
| Moderate | 1043 | 80.05 | 260 | 19.95 | |
| High | 1023 | 77.68 | 294 | 22.32 | |
| Appalachia Statusd | <0.0001 | ||||
| Non-Appalachia | 2292 | 82.45 | 488 | 17.55 | |
| Appalachia | 882 | 76.90 | 265 | 23.10 | |
|
Healthcare access | |||||
| Insurance Status | <0.0001 | ||||
| Private Insured | 601 | 81.22 | 139 | 18.78 | |
| Medicare | 2484 | 82.03 | 544 | 17.97 | |
| Medicaid | 89 | 55.97 | 70 | 44.03 | |
| Metro Statuse | <0.0001 | ||||
| Rural | 1460 | 78.24 | 406 | 21.76 | |
| Metropolitan | 1714 | 83.16 | 347 | 16.84 | |
| Hospital typesf | <0.0001 | ||||
| Academic Hospital | 100 | 62.89 | 59 | 37.11 | |
| Large Non-Academic | 2521 | 82.85 | 522 | 17.15 | |
| Small Non-Academic | 553 | 76.28 | 172 | 23.72 | |
| Great Circle Distance To Hospitalg | 0.0001 | ||||
| <10 Miles | 1651 | 82.18 | 358 | 17.82 | |
| 10–50 Miles | 1188 | 81.37 | 272 | 18.63 | |
| >50 Miles | 169 | 74.78 | 57 | 25.22 | |
| Unknown/Out of State | 166 | 71.55 | 66 | 28.45 | |
CCI, Charlson Comorbidity Index
Education attainment is categorized as a range of patients who completed high school: low (75.8–84.3%), moderate (84.4%−88.0%) and high (88.1–91.8%)
Poverty level is categorized into percentage below poverty income: high (above 18.7%), moderate (9.7–18.7%) and low (less than 9.7%)
Appalachia status is defined by 54 counties in Eastern Kentucky belong to Appalachian Regional Consortium
Metropolitan and rurality is defined based on Urban-Rural Continuum codes with the values of 1–3 as urban and 4–9 as rural
Large hospitals are defined as treating >100 cancer cases per year; Academic hospitals include University of Kentucky and University of Louisville
Great circle distance to hospital is the distance between patient residence to treatment hospital; if treatment hospital is not available, claim reporting hospital is used instead.
We found that patients diagnosed with stage I CRC (24.0%, p<0.0001) were more likely to experience DTS compared to later stage CRC (14.5% for stage II, 16.0% for stage III, and 17.8% for stage IV, and 32.7% for unknown stage, accordingly, p<0.0001). Similarly, tumor grade, which was another pathological characteristic used to categorize disease burden, was also associated with DTS. The well-differentiated group was found to have the highest percentage (26.5%) compared poorly differentiated and undifferentiated groups (16.9% and 13.2%, respectively, p<0.0001). We also investigated patient functional status, such as disability and CCI, and their association with DTS. The disabled group was found to have a slightly higher percentage in DTS (21.8%) compared to the non-disabled group in the bivariate analysis (18.0%, p = 0.0022). On the other hand, CCI was not statistically significant in contributing to DTS (Table 2).
After controlling for all significant variables, the multivariable logistic regression showed that stage I CRC was the only disease characteristic factor independently associated with DTS. Patients with Stage I disease were more likely to experience delay compared to stage IV patients (Odds Ratio (OR) 1.5, p<0.0001). Younger age, tumor grade, CCI and disability status were no longer statistically significant in the multivariable analysis (Table 3).
Table 3 –
Multivariable analysis of independent variables associated with 14-days delay in seeking specialist after colorectal cancer diagnosis on colonoscopy.
| Factors Associated with 14-days Delay to Specialist from Colorectal Cancer Diagnosis on Colonoscopy | |||
|---|---|---|---|
| Logistic Regression Analysis | |||
| Independent Variable (s) | ORa | 95% CIb | p-value |
| Age (years) | 0.0506 | ||
| 20–49 | 1.27 | 0.86–1.90 | |
| 50–64 | 1.37 | 1.05–1.79 | |
| 65–74 | 1.27 | 1.05–1.54 | |
| > 75 | Refc | ||
| Stage | <0.0001 | ||
| Stage I | 1.53 | 1.14–2.04 | |
| Stage II | 0.81 | 0.59–1.10 | |
| Stage III | 0.89 | 0.66–1.21 | |
| Stage IV | Ref | ||
| Stage Unknown | 2.08 | 1.41–3.08 | |
| CCId | 0.3083 | ||
| Score 0 | Ref | ||
| Score 1 | 1.09 | 0.90–1.33 | |
| Score 2 | 1.02 | 0.78–1.35 | |
| Score 3+ | 1.28 | 0.98–1.68 | |
| Insurance status | <0.0001 | ||
| Privately Insured | Ref | ||
| Medicare | 1.03 | 0.80–1.34 | |
| Medicaid | 3.09 | 2.12–4.50 | |
| Education attainmente | 0.0127 | ||
|
Low |
1.38 | 1.08–1.75 | |
| Moderate | 1.33 | 1.08–1.65 | |
| High | Ref | ||
| Appalachian statusf | 0.2293 | ||
| Non-Appalachia | Ref | ||
| Appalachia | 1.14 | 0.92–1.40 | |
OR, odds ratio
CI, confidence interval
Ref, reference
CCI, Charlson Comorbidity Index
Education attainment is categorized as a range of patients who completed high school: low (75.8–84.3%), moderate (84.4%–88.0%) and high (88.191.8%)
Appalachia status is defined by 54 counties in Eastern Kentucky belong to Appalachian Regional Consortium.
Socioeconomic factors: low education attainment contributed independently to DTS
Several socioeconomic risk factors found to be associated with DTS included low education attainment, high poverty level and Appalachia status from bivariate analysis. First of all, patients with low and moderate education attainment subgroups were found to have higher percentage of delay (22.4% and 20.0%, respectively, p<0.0001) compared to high education attainment subgroup (14.9%) in the bivariate analysis. As expected, high poverty index was also found to be associated with DTS (22.3%, p<0.0001). More specifically pertinent to our Kentucky population, we found that Appalachian status had a higher percentage of DTS compared to non-Appalachian subgroup (23.1% compared to 17.6%, p<0.0001) (Table 2). After controlling for all variables, we continued to observe that patients with low and moderate education attainments were more likely to experience delay compared to those patients with a high education attainment (OR 1.4 for low education and OR 1.3 for moderate education, respectively, p=0.0127) from multivariable analysis. Appalachia status, which was a proxy for low socioeconomic status, was no longer statistically significant (Table 3).
Healthcare access: Medicaid insurance status was strongly indicative of DTS
We further investigated factors impacting healthcare access, which included insurance status, rurality, hospital types and great circle distance to hospital. Most significantly, we found that there was an association between insurance type and delayed care. A further analysis revealed that our study population was comprised of a predominant 3,028 Medicare patients (77%), 740 privately insured patients (19%) and only 159 Medicaid patients (4%). The Medicaid insurance subgroup had a remarkably higher percentage of patients experiencing delay (44.0%) compared to either Medicare subgroup or privately insured subgroup from the bivariate analysis. (18.0% and 18.8%, respectively, p<0.0001) (Figure 1). Medicaid insurance status remained as a strong indicative factor contributing to DTS from multivariable analysis. These patients were more likely to experience delay compared to privately insured patients (OR 3.1, 95% CI 2.1–4.5, p<0.0001) (Table 3).
Figure 1 –
Percentage of patients experiencing 14-days Delay to Specialist among various insurance types
Next, we examined rurality as a factor and found that patients living in rural area had a higher percentage of delay compared to metropolitan residents (21.8% compared to 16.8%, p<0.0001). We also evaluated hospital type and great circle distance to hospital as two other surrogates to capture our population. Our data also suggested that patients seeking care in academic hospital and small non-academic hospitals had higher percentage of delay (37.1% and 23.7%, respectively) compare to large non-academic hospitals (17.2%, p<0.0001). Majority of patients (n=3,469, 88%) were able to receive treatment within 50 miles radius of a hospital. However, patients who traveled more than 50 miles to hospital and out-of-the-state had a higher percentage of delay within their subgroups (25.2% and 28.5%, respectively, p=0.0004) (Table 2). Nevertheless, these healthcare access factors, namely rurality, hospital type, and great circle distance to hospital, were not significant in the multivariable analysis (Table 3).
Discussion:
Our study found multiple contributing factors and identified the population at risk to experience 14-days delay in seeking specialist care after CRC diagnosis on colonoscopy. We found that stage I CRC disease, low education attainment, and Medicaid insurance status were three independent factors associated with worse DTS. These factors were particularly relevant in the eastern Kentucky Appalachian population and could potentially explain the poor cancer care outcomes.
First, our study found that patients with stage I disease were more likely to experience delays in seeking specialty care compared to patients with stage IV metastatic CRC. This finding is consistent with current literature. Previous studies suggested that locally advanced and metastatic disease were generally more symptomatic, such as rectal bleeding and weight loss (27, 41, 42). Therefore, patients with asymptomatic early stage disease may not seek medical attention promptly after CRC diagnosis (43, 44). One study found that nearly 90% of CRC were diagnosed after development of symptoms and subsequently had more advanced disease, compared to asymptomatic patients(45). The eastern Kentucky Appalachian population, which was economically distressed(26, 46), were more likely to prioritize urgent personal and financial needs over seeking medical care for asymptomatic disease(25). In addition, the Appalachians historically had lower health care utilization and lack of follow-up with referrals, which were influenced by a culture of personal privacy and pride(25). Therefore, our eastern Kentucky Appalachian patients, though not an independent contributing factor in the multivariable analysis, were particularly at risk to experience DTS, especially among asymptomatic patients.
Next, we examined socioeconomic factors and found that patients from low and moderate education attainment groups were more likely to experience delay compared to high attainment patients. Our result was well supported and consistent with existing studies that lower education level was directly associated with healthcare delay and clinical outcome (34, 44, 47). Lower education attainment rendered patients at risk for poor healthcare literacy, which had direct impact on clinical outcomes found in multiple existing studies(48–50). One study found that adults with inadequate or limited health literacy were more likely to report avoiding doctor’s visits and information about disease, and to have a more fatalistic attitudes towards cancer(51). While most of the available studies examined diagnosis delays and recapitulated the importance of screening and preventive measures in various cancer types(51–54), our study provided knowledge regarding delays in seeking a specialist after diagnosis. We observed low education attainment contributed independently to DTS from multivariable analysis. The eastern Kentucky Appalachian population was characterized by lower education ascertainment and poor healthcare literacy compared to other parts of the country (24, 55). Our population exhibited similar health-seeking behaviors and attitudes, such as under-utilization of healthcare and lack of initiative to seek prompt healthcare, comparing to non-Appalachians with low education and inadequate healthcare literacy(25). This finding further suggested that promoting patient education and healthcare literacy could shorten DTS, thus improve promptness of cancer care among eastern Kentucky Appalachians.
Finally, we evaluated healthcare access factors and identified Medicaid insurance status as an independent factor associated with DTS. Our results showed that there was a higher percentage of patient experiencing delay in the Medicaid group compared to the others. Kentucky was one of the 33 states participating in Medicaid expansion in 2016. There was 1.35 million Medicaid patients in 120 counties of Kentucky as of May 2019, which was 30.0% of the state population (56). The Medicaid enrollment rate was higher compared to the 22.2% overall US enrollment rate (57). Although previous studies have investigated the impact of Medicaid status on treatment delay, a gap in the literature exists to identify an association between Medicaid insurance and timeliness in seeking specialist care (58, 59). One likely explanation for worse DTS in the Medicaid population was the variation in distribution of resources (i.e. medical staff, treatment facilities, disparities in access), with less specialty care located in areas high with Medicaid patients(26). In addition, prior studies suggested that specialists were less likely to accept Medicaid insurance compared to general practitioners and thus, an important barrier to access for underserved population (60–63). With a high Medicaid enrollment in the state of Kentucky, our population is especially at risk of experiencing DTS from the healthcare access perspective.
The eastern Kentucky Appalachian patients are particularly vulnerable to experience DTS. This culturally and geographically isolated Appalachian population historically present with more advanced disease and less likely to seek medical attentions (25, 26). Our study also found a higher percentage of Appalachian patients in the delay group compared to the early group in the bivariate analysis, though not a statistically significant factor in multivariable analysis. The eastern Kentucky Appalachian population encompasses multiple characteristics that contributed to DTS. These factors that characterize the eastern Kentucky Appalachian population, such as Medicaid insurance status and poor education attainment, could have exerted a stronger influence, thus reducing the impact of Appalachian status statistically. This is likely the reason that we did not directly observe Appalachian status being statistically significant in the multivariable analysis. A similar result may pertain to the lack of significance found in delay associated with non-academic small hospital, greater circle distance to hospital, and rurality.
Limitations:
There were several limitations to our study. First, this was a retrospective study from a large population-based database. Retrospective data were subject to multiple confounding factors and prone to selection bias. We were not able to conduct causation analysis due to the nature of retrospective study. Secondly, our data were extracted from a claim-based KCR database and uninsured patients were unfortunately excluded from the study population. Our study was biased in terms of this exclusion criteria, and we anticipated that uninsured patients experienced worse delay compared to insured patients included in our study. Therefore, DTS could have been worse among the Kentucky population compared to our study. In addition to the factors discussed in our study, we did not include healthcare literacy, specialty availability and acceptance due to unavailability of data from the claim-based registry. These confounding factors could have had an impact on DTS, and unfortunately, could not be assessed. Lastly, our study population was predominantly (93%) Caucasians(32), which was representative with Kentucky demographics. This relative homogeneity did not allow us to observe difference among racial groups, which was suggested by previous studies. Results should be interpreted with caution when applied in a different population setting. Despite these limitations, our study found multiple factors independently contributed to delay in seeking specialist that were supported by literature. In regard to missing and unknown data in the variables collected in this study, we performed sensitivity analysis with and within missing data. This did not result in any significant discrepancy in the conclusion of this study.
Conclusion:
In summary, this study identifies stage I CRC diagnosis, low education attainment and Medicaid insurance status as independent factors contributing to delay to specialist after CRC diagnosis on colonoscopy. The eastern Kentucky Appalachian population, which encompasses several risk factors, is particularly vulnerable. Future studies and interventions should be directed towards reducing healthcare disparities and promoting patient education in the state of Kentucky.
Acknowledgement:
We would like to acknowledge and thank the Markey Cancer Center Biostatistics and Bioinformatics and Cancer Research Informatics Shared Resource Facilities of the University of Kentucky Markey Cancer Center (supported by National Cancer Institute grant P30 CA177558) for statistical analyses and for obtaining Kentucky CRC patient data and analysis from the Kentucky Cancer Registry, respectively. In addition, we thank the Center for Clinical and Translational Sciences, supported by the National Center for Advancing Translational Sciences grant UL1 TR001998, for assistance with data extraction. Dr. Zeta Chow is supported by and National Cancer Institute postdoctoral training grant T32 CA160003. Bin Huang and Quan Chen are supported by the Centers of Disease Control and Prevention (IU48DP005014-07 SIP14-017). Additionally, Bin Huang is supported by the National Cancer Center Support Grant (P30 CA177558). The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of the grant funding agencies.
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- 1.Siegel RL, Miller KD, Jemal A Cancer statistics, 2019. CA: a cancer journal for clinicians 2019:69:7–34. [DOI] [PubMed] [Google Scholar]
- 2.American Cancer Society. Cancer Facts & Figures 2019. Atlanta: American Cancer Society; 2019. [Google Scholar]
- 3.Blackley D, Behringer B, Zheng S Cancer mortality rates in Appalachia: descriptive epidemiology and an approach to explaining differences in outcomes. Journal of community health 2012:37:804–813. [DOI] [PubMed] [Google Scholar]
- 4.Meissner HI, Klabunde CN, Breen N, Zapka JM Breast and colorectal cancer screening: US primary care physicians’ reports of barriers. American journal of preventive medicine 2012:43:584–589. [DOI] [PubMed] [Google Scholar]
- 5.Knight JR, Kanotra S, Siameh S, Jones J, Thompson B, et al. Peer Reviewed: Understanding Barriers to Colorectal Cancer Screening in Kentucky. Preventing chronic disease 2015:12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Bennett J, Kanotra S, Redmond J, Reffett S, Thomas-Cox S Barriers to colon cancer screening in Kentucky. J Ky Med Assoc 2011:109:55–62. [Google Scholar]
- 7.Klabunde CN, Joseph DA, King JB, White A, Plescia M Vital signs: colorectal cancer screening test use—United States, 2012. MMWR. Morbidity and mortality weekly report 2013:62:881. [PMC free article] [PubMed] [Google Scholar]
- 8.Dignan M, Shelton B, Slone SA, Tolle C, Mohammad S, et al. Effectiveness of a primary care practice intervention for increasing colorectal cancer screening in Appalachian Kentucky. Preventive medicine 2014:58:70–74. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Gan T, Sinner HF, Walling SC, Chen Q, Huang B, et al. Impact of the Affordable Care Act on Colorectal Cancer Screening, Incidence, and Survival in Kentucky. Journal of the American College of Surgeons 2019:228:342–353. e341. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Neal RD, Tharmanathan P, France B, Din NU, Cotton S, et al. Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. British journal of cancer 2015:112 Suppl 1:S92–107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Guzman Laura KP, Bolibar Ribas I, Alepuz MT, Gonzalez D, Martin M Impact on patient care time and tumor stage of a program for fast diagnostic and treatment of colorectal cancer. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 2011:103:13–19. [DOI] [PubMed] [Google Scholar]
- 12.Currie AC, Evans J, Smith NJ, Brown G, Abulafi AM, et al. The impact of the two-week wait referral pathway on rectal cancer survival. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 2012:14:848–853. [DOI] [PubMed] [Google Scholar]
- 13.Flashman K, O’Leary DP, Senapati A, Thompson MR The Department of Health’s “two week standard” for bowel cancer: is it working? Gut 2004:53:387–391. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Faiz O Association of Coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the Management of Cancer of the Colon, Rectum and Anus (2017) - Audit and Outcome Reporting. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 2017:19 Suppl 1:71–73. [DOI] [PubMed] [Google Scholar]
- 15.Valentin-Lopez B, Ferrandiz-Santos J, Blasco-Amaro JA, Morillas-Sainz JD, Ruiz-Lopez P Assessment of a rapid referral pathway for suspected colorectal cancer in Madrid. Family practice 2012:29:182–188. [DOI] [PubMed] [Google Scholar]
- 16.Walsh S, Bruce C, Bennington S, Ravi S The fourteen-day rule and colorectal cancer. Annals of the Royal College of Surgeons of England 2002:84:386–388. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Zafar A, Mak T, Whinnie S, Chapman MA The 2-week wait referral system does not improve 5-year colorectal cancer survival. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 2012:14:e177–180. [DOI] [PubMed] [Google Scholar]
- 18.Korsgaard M, Pedersen L, Laurberg S Delay of diagnosis and treatment of colorectal cancer--a population-based Danish study. Cancer detection and prevention 2008:32:45–51. [DOI] [PubMed] [Google Scholar]
- 19.Cunningham C, Leong K, Clark S, Plumb A, Taylor S, et al. Association of Coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the Management of Cancer of the Colon, Rectum and Anus (2017) – Diagnosis, Investigations and Screening. Colorectal Disease 2017:19:9–17. [DOI] [PubMed] [Google Scholar]
- 20.Probst HB, Hussain ZB, Andersen O Cancer patient pathways in Denmark as a joint effort between bureaucrats, health professionals and politicians—a national Danish project. Health Policy 2012:105:65–70. [DOI] [PubMed] [Google Scholar]
- 21.van Harten MC, Hoebers FJ, Kross KW, van Werkhoven ED, van den Brekel MW, et al. Determinants of treatment waiting times for head and neck cancer in the Netherlands and their relation to survival. Oral oncology 2015:51:272–278. [DOI] [PubMed] [Google Scholar]
- 22.Di Girolamo C, Walters S, Gildea C, Majano SB, Rachet B, et al. Can we assess Cancer Waiting Time targets with cancer survival? A population-based study of individually linked data from the National Cancer Waiting Times monitoring dataset in England, 2009–2013. PloS one 2018:13:e0201288. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Markey Cancer Center. UK Healthcare. https://ukhealthcare.uky.edu/markey-cancer-center.
- 24.Ludke RL, Obermiller PJ, Jacobson CJ Jr, Shaw T, Wells VE “ Sometimes It’s Hard to Figure”: The Functional Health Literacy of Appalachians in a Metropolitan Area. Journal of Appalachian studies 2006:7–25. [Google Scholar]
- 25.Behringer B, Friedell GH, Dorgan KA, Hutson SP, Naney C, et al. Understanding the Challenges of Reducing Cancer in Appalachia. Californian Journal of Health Promotion 2007:5:40–49. [Google Scholar]
- 26.Lane NM, Lutz AY, Baker K, Konrad TR, Ricketts TC, et al. Health care costs and access disparities in Appalachia. Citeseer, 2012. [Google Scholar]
- 27.Inada R, Nagasaka T, Watanabe A, Yagi T, Mori Y, et al. Comparison of outcomes between symptomatic and asymptomatic patients with colorectal cancer: a propensity score-matched analysis of surgical invasiveness, medical costs and oncological outcomes. BMJ open gastroenterology 2017:4:e000146. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Thorne AL, Mercer SJ, Harris GJC, Simson JNL Reduction in late diagnosis of colorectal cancer following introduction of a specialist colorectal surgery service. Annals of the Royal College of Surgeons of England 2006:88:562–565. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Amin MBae AJCC Cancer Staging Manual. 2017.
- 30.Overview of the SEER Program. National Cancer Institute. [Google Scholar]
- 31.Lai S-M, Jungk J, Garimella S Peer Reviewed: Colorectal Cancer Identification Methods Among Kansas Medicare Beneficiaries, 2008–2010. Preventing chronic disease 2015:12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.County Economic Status, Fiscal Year 2019: Appalachian Kentucky. 2019.
- 33.Great Circle Distance SAS Program. NAACCR GIS Committee. [Google Scholar]
- 34.Aarts MJ, Lemmens VE, Louwman MW, Kunst AE, Coebergh JW Socioeconomic status and changing inequalities in colorectal cancer? A review of the associations with risk, treatment and outcome. European journal of cancer (Oxford, England : 1990) 2010:46:2681–2695. [DOI] [PubMed] [Google Scholar]
- 35.Burnley IH Disadvantage and male cancer incidence and mortality in New South Wales 1985–1993. Social science & medicine (1982) 1997:45:465–476. [DOI] [PubMed] [Google Scholar]
- 36.Steenland K, Hu S, Walker J All-cause and cause-specific mortality by socioeconomic status among employed persons in 27 US states, 1984–1997. American journal of public health 2004:94:1037–1042. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Pollock AM, Vickers N Breast, lung and colorectal cancer incidence and survival in South Thames Region, 1987–1992: the effect of social deprivation. Journal of public health medicine 1997:19:288–294. [DOI] [PubMed] [Google Scholar]
- 38.Egner JR AJCC Cancer Staging Manual. Jama 2010:304:1726–1727. [Google Scholar]
- 39.Deyo RA, Cherkin DC, Ciol MA Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. Journal of Clinical Epidemiology 1992:45:613–619. [DOI] [PubMed] [Google Scholar]
- 40.STROBE statement.
- 41.Van Hout AM, de Wit NJ, Rutten FH, Peeters PH Determinants of patient’s and doctor’s delay in diagnosis and treatment of colorectal cancer. European journal of gastroenterology & hepatology 2011:23:1056–1063. [DOI] [PubMed] [Google Scholar]
- 42.Leijssen LGJ, Dinaux AM, Kunitake H, Bordeianou LG, Berger DL Detrimental impact of symptom-detected colorectal cancer. Surgical endoscopy 2019. [DOI] [PubMed] [Google Scholar]
- 43.Abu-Helalah MA, Alshraideh HA, Da’na M, Al-Hanaqtah M, Abuseif A, et al. Delay in Presentation, Diagnosis and Treatment for Colorectal Cancer Patients in Jordan. Journal of gastrointestinal cancer 2016:47:36–46. [DOI] [PubMed] [Google Scholar]
- 44.Zarcos-Pedrinaci I, Fernandez-Lopez A, Tellez T, Rivas-Ruiz F, Rueda A, et al. Factors that influence treatment delay in patients with colorectal cancer. Oncotarget 2017:8:36728–36742. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Moreno CC, Mittal PK, Sullivan PS, Rutherford R, Staley CA, et al. Colorectal cancer initial diagnosis: screening colonoscopy, diagnostic colonoscopy, or emergent surgery, and tumor stage and size at initial presentation. Clinical colorectal cancer 2016:15:67–73. [DOI] [PubMed] [Google Scholar]
- 46.County Economic Status, Fiscal Year 2019. Appalachian Regional Comission. [Google Scholar]
- 47.Cavalli-Bjorkman N, Lambe M, Eaker S, Sandin F, Glimelius B Differences according to educational level in the management and survival of colorectal cancer in Sweden. European journal of cancer (Oxford, England : 1990) 2011:47:1398–1406. [DOI] [PubMed] [Google Scholar]
- 48.Aboumatar HJ, Carson KA, Beach MC, Roter DL, Cooper LA The impact of health literacy on desire for participation in healthcare, medical visit communication, and patient reported outcomes among patients with hypertension. Journal of general internal medicine 2013:28:1469–1476. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Morris NS, MacLean CD, Littenberg B Literacy and health outcomes: a cross-sectional study in 1002 adults with diabetes. BMC family practice 2006:7:49. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Berkman ND, Sheridan SL, Donahue KE, Halpern DJ, Viera A, et al. Health literacy interventions and outcomes: an updated systematic review. Evid Rep Technol Assess (Full Rep) 2011:199:941. [PMC free article] [PubMed] [Google Scholar]
- 51.Morris NS, Field TS, Wagner JL, Cutrona SL, Roblin DW, et al. The association between health literacy and cancer-related attitudes, behaviors, and knowledge. Journal of health communication 2013:18:223–241. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Kaku M, Mathew A, Rajan B Impact of socio-economic factors in delayed reporting and late-stage presentation among patients with cervix cancer in a major cancer hospital in South India. Asian Pac J Cancer Prev 2008:9:589–594. [PubMed] [Google Scholar]
- 53.Agarwal A, Sethi A, Sareen D, Dhingra S Treatment delay in oral and oropharyngeal cancer in our population: the role of socio-economic factors and health-seeking behaviour. Indian Journal of Otolaryngology and Head & Neck Surgery 2011:63:145–150. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Jassem J, Ozmen V, Bacanu F, Drobniene M, Eglitis J, et al. Delays in diagnosis and treatment of breast cancer: a multinational analysis. The European Journal of Public Health 2014:24:761–767. [DOI] [PubMed] [Google Scholar]
- 55.Rodriguez SD, Vanderford NL, Huang B, Vanderpool RC A Social-Ecological Review of Cancer Disparities in Kentucky. Southern medical journal 2018:111:213–219. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Cabinet for Health and Family Services. State of Kentucky Department of Medicaid Monthly Membership Counts by County. https://chfs.ky.gov/agencies/dms/Pages/default.aspx.
- 57.Medicaid Enrollment rate. Medicaid program monthly highlight. www.medicaid.gov.. [Google Scholar]
- 58.Adamson BJS, Cohen AB, Estevez M, Magee K, Williams E, et al. Affordable Care Act (ACA) Medicaid expansion impact on racial disparities in time to cancer treatment. Journal of Clinical Oncology 2019:37:LBA1–LBA1. [Google Scholar]
- 59.Bilimoria KY, Ko CY, Tomlinson JS, Stewart AK, Talamonti MS, et al. Wait times for cancer surgery in the United States: trends and predictors of delays. Annals of surgery 2011:253:779–785. [DOI] [PubMed] [Google Scholar]
- 60.Kim C-Y, Wiznia DH, Roth AS, Walls RJ, Pelker RR Survey of patient insurance status on access to specialty foot and ankle care under the Affordable Care Act. Foot & ankle international 2016:37:776–781. [DOI] [PubMed] [Google Scholar]
- 61.Backus L, Osmond D, Grumbach K, Vranizan K, Phuong L, et al. Specialists’ and primary care physicians’ participation in Medicaid managed care. Journal of General Internal Medicine 2001:16:815–821. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Ferrer RL Pursuing equity: contact with primary care and specialist clinicians by demographics, insurance, and health status. The Annals of Family Medicine 2007:5:492–502. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Cook NL, Hicks LS, O’Malley AJ, Keegan T, Guadagnoli E, et al. Access to specialty care and medical services in community health centers. Health Affairs 2007:26:1459–1468. [DOI] [PubMed] [Google Scholar]

